Research Roundup

Debbie Rigby 21/10/2025

Debbie Rigby rounds up the latest in research news Safety of menopause hormone therapy in postmenopausal women at higher risk of venous thromboembolism A systematic review has concluded that transdermal menopause hormone therapy appears safe in women with risk factors for venous thromboembolism (VTE). Oral menopause hormone therapy, notably oral estrogen plus a synthetic progestogen,

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

This web site is intended for Australian pharmacy professionals and is not a substitute for independent professional advice. Information and interactions contained in this website are for information purposes only and are not intended to be used to diagnose, treat, cure or prevent any disease. Further the accuracy, currency and completeness of the information available on this web site cannot be guaranteed. APPco Pty Ltd, its affiliates and their respective servants and agents do not accept any liability for any injury, loss or damage incurred by use of or reliance on the information made available via or through ajp.com.au whether arising from negligence or otherwise.

Research Roundup

Previous Tassie premier lauds pharmacist UTI service

Next Sunscreen recall list grows

MENU

ajp.com.au

Previous Tassie premier lauds pharmacist UTI service

Next Sunscreen recall list grows

MENU

ajp.com.au

Tags

Hi there! 👋 Looks like you’re not logged in.